Monday, July 20, 2026

Intelligence · Clinical pipeline

Infectious disease R&D Pipeline

Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Programs 16

Quick answer

Infectious disease: NovaPharmaNews indexes 16 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Top sponsors

Pipeline programs

  1. ITDCVC98

    United Therapeutics Europe Ltd

    Malaria

    phase 3 small molecule completed

    1 trial
  2. Telbivudine

    Novartis Pharmaceuticals

    Hepatitis

    phase 3 small molecule completed

    1 trial
  3. 413ABM

    BRIGHT MINDS BIOSCIENCES INC.

    MALARIA

    phase 2 other completed

    1 trial
  4. DNA vaccine prime

    United Therapeutics Europe Ltd

    Malaria

    phase 2 mab completed

    1 trial
  5. Immunization with P. vivax irradiated sporozoites

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria

    phase 2 mab completed

    1 trial
  6. Vaccine PvCS N+C+R

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria

    phase 2 mab completed

    1 trial
  7. Chloroquine

    GlaxoSmithKline

    Malaria

    phase 1 small molecule completed

    1 trial
  8. D/ChAd63-CA

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial
  9. FMP012 with AS01B adjuvant system

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial
  10. FMP1/AS02A

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial
  11. Group 1: 10 ug FMP012 with 2 ug GLA-SE

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial
  12. Plasmodium falciparum Malaria Protein 010 (FMP010)

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial
  13. AL (Coartem)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial
  14. Amodiaquine plus Artesunate co-administration

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial
  15. Coartem™ (Artemether-lumefantrine combination)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial
  16. Ursodeoxycholic acid combined with total glucosides of paeony

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis

    approved small molecule active

    1 trial

Frequently asked questions

How many infectious disease pipeline programs are tracked?

16 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.